We use FDA-approved GLP-1 medications to address the physiological barriers to weight loss but we pair them with InBody body composition scanning, nutritional guidance, and support for the mental and behavioral patterns that determine whether results last
Semaglutide may support appetite regulation, but insulin resistance may still need to be addressed as part of a broader medical plan
Long-term users report enhanced energy levels, reduced joint stress from lower body weight, and improved metabolic health metrics across lipid panels and glucose tolerance tests
Evaluation of oxidative stress status and antioxidant capacity in patients with painful bladder syndrome/interstitial cystitis: preliminary results of a randomised study
Another animal study showed that the administration of vascular growth factors led to penile neovascularization, a possible long-term solution to vasculogenic ED [13, 14]
The STEP and SUSTAIN trial data provide robust evidence of systemic anti-inflammatory effects